BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,126 | +3.0% | 6,336 | +24.3% | 0.01% | 0.0% |
| Q2 2023 | $232,257 | +20.0% | 5,098 | +6.8% | 0.01% | +20.0% |
| Q1 2023 | $193,536 | -22.8% | 4,772 | -3.0% | 0.01% | -37.5% |
| Q4 2022 | $250,663 | +18.8% | 4,918 | +25.3% | 0.01% | +14.3% |
| Q3 2022 | $211,000 | -29.0% | 3,926 | -14.9% | 0.01% | -30.0% |
| Q2 2022 | $297,000 | -24.2% | 4,616 | -8.5% | 0.01% | -16.7% |
| Q1 2022 | $392,000 | -11.9% | 5,044 | -2.9% | 0.01% | -7.7% |
| Q4 2021 | $445,000 | +12.1% | 5,194 | +5.5% | 0.01% | 0.0% |
| Q3 2021 | $397,000 | +3.1% | 4,922 | +2.8% | 0.01% | +8.3% |
| Q2 2021 | $385,000 | +4.9% | 4,787 | +10.3% | 0.01% | -14.3% |
| Q1 2021 | $367,000 | +56.8% | 4,339 | +48.7% | 0.01% | +55.6% |
| Q4 2020 | $234,000 | -53.9% | 2,917 | -53.8% | 0.01% | -62.5% |
| Q3 2020 | $508,000 | +61.8% | 6,319 | +73.4% | 0.02% | +41.2% |
| Q2 2020 | $314,000 | +63.5% | 3,645 | +55.0% | 0.02% | +30.8% |
| Q1 2020 | $192,000 | -35.4% | 2,351 | -33.8% | 0.01% | -18.8% |
| Q4 2019 | $297,000 | +18.8% | 3,554 | +16.5% | 0.02% | +6.7% |
| Q3 2019 | $250,000 | 0.0% | 3,050 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $250,000 | +47.9% | 3,050 | +47.0% | 0.02% | +25.0% |
| Q1 2019 | $169,000 | +19.0% | 2,075 | -3.8% | 0.01% | 0.0% |
| Q4 2018 | $142,000 | -17.4% | 2,156 | -3.6% | 0.01% | -7.7% |
| Q3 2018 | $172,000 | -29.5% | 2,236 | -32.5% | 0.01% | -31.6% |
| Q2 2018 | $244,000 | +4.3% | 3,312 | -8.1% | 0.02% | 0.0% |
| Q1 2018 | $234,000 | +63.6% | 3,604 | +63.4% | 0.02% | +58.3% |
| Q4 2017 | $143,000 | +25.4% | 2,205 | +21.6% | 0.01% | -7.7% |
| Q3 2017 | $114,000 | +15.2% | 1,814 | +10.5% | 0.01% | 0.0% |
| Q2 2017 | $99,000 | +25.3% | 1,641 | +8.4% | 0.01% | +18.2% |
| Q1 2017 | $79,000 | +23.4% | 1,514 | +12.3% | 0.01% | -8.3% |
| Q3 2016 | $64,000 | +137.0% | 1,348 | +107.4% | 0.01% | +71.4% |
| Q1 2016 | $27,000 | +12.5% | 650 | +5.3% | 0.01% | -12.5% |
| Q4 2015 | $24,000 | -45.5% | 617 | -54.1% | 0.01% | -38.5% |
| Q3 2015 | $44,000 | -67.2% | 1,343 | -30.1% | 0.01% | -67.5% |
| Q2 2015 | $134,000 | -5.6% | 1,921 | -7.3% | 0.04% | +2.6% |
| Q1 2015 | $142,000 | +24.6% | 2,073 | +30.2% | 0.04% | +8.3% |
| Q4 2014 | $114,000 | +46.2% | 1,592 | +41.4% | 0.04% | -7.7% |
| Q4 2013 | $78,000 | – | 1,126 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |